Skip to content
DataLookout
Menu

AIMSSNCT07825454

Pilot Study of Hydroxychloroquine for the Treatment of AIMSS

StatusRecruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Start date changed from estimate of Sep 2026 to Oct 19, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

To evaluate the efficacy of hydroxychloroquine
Timeframe: Day 1 and Week 12

Secondary (8)

Proportion of patients achieving a clinically meaningful improvement
Changes in BPI Worst Pain and Pain Interference scores
Changes in endocrine therapy related quality of life
Changes in grip strength
Patient-reported global impression of change
Show 3 moreShow less
Safety of hydroxychloroquine in this patient population
Tolerability of hydroxychloroquine in this patient population
Adherence to aromatase inhibitor therapy

Arms and interventions

Hydroxychloroquine sulfateExperimental

Hydroxychloroquine sulfate, 400 mg orally once daily

Drugs: Hydroxychloroquine Sulfate (HCQ)

Sites

1 site in 1 country

  • Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, Indiana, United States